![](/img/cover-not-exists.png)
A phase I study of combined modality fever-range, long-duration, low-temperature whole-body hyperthermia (LL-WBH) optimally-timed with cisplatin (CIS)-gemcitabine (GEM) & interferon-a (IFN-a)
J. Bull, G. Scott, V. Nagle, F. Strebel, S. KochVolume:
37
Year:
2001
Language:
english
DOI:
10.1016/s0959-8049(01)80763-2
File:
PDF, 164 KB
english, 2001